umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Phase 2 open-label extension (OLE) study of patisiran with or without a TTR stabilizer for the treatment of hereditary ATTR (hATTR) amyloidosis with polyneuropathy
Show others and affiliations
2017 (English)In: European Journal of Neurology, ISSN 1351-5101, E-ISSN 1468-1331, Vol. 24, p. 31-32Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
WILEY , 2017. Vol. 24, p. 31-32
National Category
Neurology
Identifiers
URN: urn:nbn:se:umu:diva-140983DOI: 10.1111/ene.13366ISI: 000405530100053OAI: oai:DiVA.org:umu-140983DiVA, id: diva2:1154029
Conference
3rd Congress of the European-Academy-of-Neurology, JUN, 2017, Amsterdam, NETHERLANDS
Available from: 2017-11-01 Created: 2017-11-01 Last updated: 2018-06-09Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full text

Authority records BETA

Suhr, Ole

Search in DiVA

By author/editor
Suhr, Ole
By organisation
Medicine
In the same journal
European Journal of Neurology
Neurology

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 1056 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf